The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation

Journal of Cutaneous Pathology

Volumn 24, Issue 7, 1997, Pages 403-408

  Li, Guoqing ^a   Salhany, Kevin E ^a   Rook, Alain H ^a   Lessin, Stuart R ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; MESSENGER RNA; NUCLEOPHOSMIN;

ARTICLE; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; T CELL LYMPHOMA;

ANTIGENS, CD30; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0030773225     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb00814.x     Document Type: Article

References (35)

1. Greer J, Salhany K, King L. Cutaneous T cell lymphoma: mycosis fungiodes and Sézary syndrome. In: Lee et al., eds. Clinical Hematology (9th edn). Philadelphia: Lea & Febfiger, 1993: 2143.
2. Salhany KE, Cousar JB, Greer JP, Casey TT, Fields JP, Collins RD. Transformation of cutaneous T cell lymphoma to large cell lymphoma: A clinicopathologic and immunologic study. Am J Pathol 1988: 132: 265.
3. Cerroni L, Reiger E, Hodl S, Kerl H. Clinicopathologic and immunologic features associated with transformation of mycosis fungoids to large-cell lymphoma. Am J Surg Pathol 1992: 16: 543.
4. Kaudewitz P, Stein H, Dallenbach F, et al. Primary and secondary cutaneous Ki-1 (CD30+) anaplastic large cell lymphomas: Morphologic, immunohistological, and clinical characteristics. Am J Pathol 1989: 135: 359.
5. Dmitrovsky E, Mattews MJ, Bunn PA, et al. Cytologic transformation in cutaneous T cell lymphoma: A Clinicopathologic entity associated with poor prognosis. J Clin Oncol 1987: 5: 208.
6. Wolfe JT, Chooback L, Finn DT, Jaworsky C, Rook AH, Lessin S. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: Molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor. J Clin Oncol 1995: 13: 1751.
7. Wood G, Bahler D, Hoppe R, et al. Transformation of mycosis fungoides: T cell receptor β gene analysis demonstrates a common clonal orgin for plaque-type mycosis fungoides and CD30+ positive large cell lymphoma. J Invest Dermatol 1993: 101: 296.
8. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985: 66: 848.
9. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classfication of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994: 84: 1361.
10. Falini B, Pileri S, Pizzolo G, et al. CD30 (Ki-1) Molecule: A new cytokine receptor of the tumor necrosis factor superfamily as a tool for diagnosis and immunotherapy. Blood 1995: 85: 1.
11. Rimokh R, Magaud J-P, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphomas (Ki-1 lymphoma). Br J Haematol 1989: 71: 31.
12. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994: 263: 1281.
13. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M. Analysis of the t(2;5) (p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of the T-cell phenotype, and in Hodgkin's disease. Blood 1995b: 86: 2321.
14. Downing JR, Shurtleff SA, Zielenska M, et al. Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 1995: 85: 3416.
15. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM. Nucleophosmin (NPM) gene rearrangement in Ki-1-positive lymphomas. Cancer Res 1994: 54: 2873.
16. DeCoteau JF, Butmarc JR, Kinney MC, Kadin KE. The t(2;5) chromosomal translocation is not a common feature cutaneous CD30+ lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996: 87: 3437.
17. Shito M, Fujimoto J, Takenaga M, et al. Diagnosis of t(2;5)(p23;q.35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994; 84: 3648.
18. Wood GS, Hardman DL, Boni R, et al. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase (ALK) catalytic domain in CD30+ primary lymphoproliferative disorders and Hodgkin's disease. Blood 1996: in press.
19. Beylot-Barry M, Lamant L, Vergier B, et al. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996: 149: 483.
20. Stansfeld AG, Diebold J, Noel H, et al. Updated Ki-1 classification for lymphomas. Lancet 1988: 1: 292.
21. Lennert K, Feller AC. Histopathology of non-Hodgkin's lymphomas (2nd revised edition). New York, Berlin, Heidelberg: Spring Verlag, 1992.
22. Harris NL, Ferry JA. Follicular lymphoma and related disorders (germinal center lymphomas). In: Knowles DM (ed.). Neoplastic Hematopathology. 1st edn. Baltimore, MD: Williams and Wilkins, 1992: 651.
23. Shapiro PE, Warburton D, Berger CL, Edelson RL. Clonal chromosomal abnormalities in cutaneous T-cell lymphoma. Cancer Genet Cytogenet 1987: 28: 267.
24. Lauritzen AF, Vejlsgaard GL, Hou-Jensen K, Ralfkiaer E. p53 protein expression in cutaneous T-cell lymphomas. Br J Dermatol 1995: 133: 32.
25. McGregor JM, Crook T, Ng B, Smith NP, Wittaker S. p53 gene mutations in cutaneous T cell lymphoma (abstract). J Invest Dermatol 1996: 106: 855.
26. Chooback L, Felix CA, Salhany KE, et al. Overexpression of p53 protein in cutaneous T-cell lymphoma (CTCL): Relationship to large cell transformation (LCT) & disease progression (abstract). J Invest Dermatol 1995: 104: 674.
27. Lamant L, Meggetto F, Al Saati T, et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease: Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p80 immunostaining. Blood 1996: 87: 284.
28. Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC. Transcription of the npm-alk fusion gene in anaplastic large cell lymphonia, Hodgkin's disease, and reactive lymphoid lesions. Blood 1996: 86: 3517.
29. Sarris AH, Luthra R, Papadimitracopoulou V, et al. Amplification of genomic DNA demonstrate the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's disease, or lymphomatoid papulosis. Blood 1996: 88: 1771.
30. Yee HT, Ponzoni M, Merson A, et al. Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphonia (Ki-1) and Hodgkin's disease. Blood 1996: 87: 1081.
31. Lopategui JR, Sun L-H, Chan JKC, et al. Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. Am J Pathol 1995: 146: 323.
32. Weisenberger DD, Gordon BG, Vose JM, et al. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood 1996: 87: 3860.
33. Ladanyi M, Cavalchire G, Morris SW, Douning J, Filippa DA. Reverse transriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol 1994: 145: 1296.
34. Weiss LM, Lopategui JR, Sun L-H, Kamel OW, Koo CH, Glackin C. Absence of the t(2;5) in Hodgkin's disease. Blood 1995: 85: 2845.
35. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC. Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: indication of a common pathogenesis. Lancet 1995: 345: 87.